A microRNA driver of B-cell leukaemia
A microRNA driver of B-cell leukaemia
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients
Blinatumomab improves survival of relapsed B-cell leukaemia
Decoding the risk of thromboembolic events in lymphoma patients
SL401 in patients with rare neoplasm
RNA regulation of JAK-STAT pathways in CML
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence
An overview of MCL from EHA 2016
The value and strategy for incorporating biosimilars Into clinical practice
Checkpoint inhibitor therapy benefits advanced bladder cancer patients
Neuroblastoma outcomes improved with second stem cell transplant
Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer